John Gunn - Dodge & Cox
Holding/activity history for GSK plc (GSK)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 58,662,974 | 1.78 | Reduce 14.38% | 0.26 | $55.19 | $3,237,609,535 | SEC |
| 2025 Q4 | 68,517,969 | 1.81 | Reduce 12.61% | 0.23 | $49.04 | $3,360,121,200 | SEC |
| 2025 Q3 | 78,403,734 | 1.83 | Reduce 0.45% | <0.01 | $43.16 | $3,383,905,159 | SEC |
| 2025 Q2 | 78,757,869 | 1.70 | Add 0.13% | <0.01 | $38.40 | $3,024,302,170 | SEC |
| 2025 Q1 | 78,651,833 | 1.74 | Add 14.92% | 0.23 | $38.74 | $3,046,972,010 | SEC |
| 2024 Q4 | 68,440,912 | 1.35 | Add 0.52% | <0.01 | $33.82 | $2,314,671,644 | SEC |
| 2024 Q3 | 68,087,163 | 1.57 | Reduce 0.37% | <0.01 | $40.88 | $2,783,403,223 | SEC |
| 2024 Q2 | 68,337,138 | 1.58 | Reduce 0.76% | 0.01 | $38.50 | $2,630,979,813 | SEC |
| 2024 Q1 | 68,862,308 | 1.71 | Reduce 0.24% | <0.01 | $42.87 | $2,952,127,144 | SEC |
| 2023 Q4 | 69,026,793 | 1.62 | Reduce 0.37% | <0.01 | $37.06 | $2,558,132,949 | SEC |
| 2023 Q3 | 69,281,183 | 1.70 | Reduce 0.47% | <0.01 | $36.25 | $2,511,442,884 | SEC |
| 2023 Q2 | 69,611,268 | 1.66 | Reduce 0.14% | <0.01 | $35.64 | $2,480,945,592 | SEC |
| 2023 Q1 | 69,707,068 | 1.70 | Add 7.35% | 0.12 | $35.58 | $2,480,177,479 | SEC |
| 2022 Q4 | 64,932,952 | 1.57 | Add 10.84% | 0.15 | $35.14 | $2,281,743,933 | SEC |
| 2022 Q3 | 58,583,989 | 1.31 | Buy | 1.31 | $29.43 | $1,724,127,000 | SEC |